Market Pulse Archives

May 24, 2022, 12:35 p.m. EDT

Moderna says it will start developing a monkeypox vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Moderna Inc. (MRNA)
  • X
    S&P 500 Index (SPX)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Moderna Inc. /zigman2/quotes/205619834/composite MRNA +0.44% tweeted Monday afternoon that it is "investigating potential monkeypox vaccines at a preclinical level." Several stocks of companies that are developing or have smallpox or monkeypox vaccines and treatments jumped in trading on Monday as more people have become aware of the cluster of cases in Europe. Moderna's stock is down 48.3% so far this year, while the broader S&P 500 /zigman2/quotes/210599714/realtime SPX -0.07% has declined 16.6%.

/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 142.81
+0.62 +0.44%
Volume: 2.91M
June 29, 2022 4:00p
P/E Ratio
4.20
Dividend Yield
N/A
Market Cap
$56.56 billion
Rev. per Employee
$8.34M
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,818.83
-2.72 -0.07%
Volume: 2.11B
June 29, 2022 5:16p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.